Compare Eli Lilly And Co (LLY) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Nuwellis Inc — how do they compare? Eli Lilly And Co trades at $1,212 (market cap $1.08T), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: Eli Lilly And Co is far larger — about 1989683.1× Nuwellis Inc's market cap, and Eli Lilly And Co pays a 0.57% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| LLY | NUWE | |
|---|---|---|
Market Cap | $1.08T | $542.80K |
Sector | Health | Technology |
52-Week High | $1.24K | $220.50 |
52-Week Low | $639.43 | $1.42 |
Enterprise Value | $1.13T | -$1.27M |
Dividend Yield | 0.57% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
